Proliferation and apoptosis before and after primary systemic therapy for operable breast cancer

被引：0
|
作者：
Guarneri, V.
Piacentini, F.
Frassoldati, A.
Ficarra, G.
Jovic, G.
Puglisi, F.
Michelotti, A.
Bisagni, G.
Berardi, R.
Conte, P.
机构：
[1] Univ Modena & Reggio Emilia, Modena, Italy
[2] Univ Hosp, Udine, Italy
[3] S Chara Univ Hosp, Pisa, Italy
[4] Arcispedale S Maria Nuova, Reggio Emilia, Italy
[5] Univ Hosp, Ancona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21045
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Primary systemic therapy in breast cancer
    Goehring, Uwe-Jochen
    Solomayer, Erich
    [J]. BREAST CARE, 2006, 1 (04) : 234 - 237
  • [22] Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer
    Tokes, Timea
    Tokes, Anna-Maria
    Szentmartoni, Gyongyver
    Kiszner, Gergo
    Muhl, Dorottya
    Molnar, Bela Akos
    Kulka, Janina
    Krenacs, Tibor
    Dank, Magdolna
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1499 - 1510
  • [23] MRI of the breast before and after primary systemic therapy correlates with histopathological outcome in patients with locally advanced breast cancer (LABC).
    Russu, VI
    Lex, B
    Gilster, T
    Pfaffenberger, K
    Volkholz, H
    Grossmann, A
    Tulusan, AH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 885S - 885S
  • [24] Proliferation and apoptosis before and after radiochemotherapy in rectal cancer
    Tannapfel, A
    Nusslein, S
    Katalinic, A
    Kockerling, F
    Wittekind, C
    Fietkau, R
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 1998, 174 (06) : 295 - 299
  • [25] Prognostic value of the systemic inflammation response index (SIRI) before and after surgery in operable breast cancer patients
    Wang, Lei
    Zhou, Yehui
    Xia, Suhua
    Lu, Linlin
    Dai, Tiantian
    Li, Aoshuang
    Chen, Yan
    Gao, Erli
    [J]. CANCER BIOMARKERS, 2020, 28 (04) : 537 - 547
  • [26] ABC OF BREAST DISEASES - ROLE OF SYSTEMIC TREATMENT FOR PRIMARY OPERABLE BREAST-CANCER
    RICHARDS, MA
    SMITH, IE
    DIXON, JM
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6965): : 1363 - 1366
  • [27] Neoadjuvant Chemotherapy for Operable Breast Cancer: Individualizing Locoregional and Systemic Therapy
    Bear, Harry D.
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (03) : 607 - +
  • [28] SYSTEMIC THERAPY AS THE INITIAL STEP IN THE MANAGEMENT OF OPERABLE BREAST-CANCER
    PAPAIOANNOU, AN
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 1984, 64 (06) : 1181 - 1191
  • [29] Oestrogen receptor directed primary systemic therapy: a randomised trial compared with conventional therapy in operable breast cancer.
    Cameron, DA
    Jack, W
    Forouhi, P
    Keen, J
    Dixon, JM
    Leonard, RCF
    Chetty, U
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S52 - S52
  • [30] Research issues affecting preoperative systemic therapy for operable breast cancer
    Wolff, Antonio C.
    Berry, Donald
    Carey, Lisa A.
    Colleoni, Marco
    Dowsett, Mitchell
    Ellis, Matthew
    Garber, Judy E.
    Mankoff, David
    Paik, Soonmyung
    Pusztai, Lajos
    Smith, Mary Lou
    Zujewski, JoAnne
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) : 806 - 813
12345